AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by AC Immune SA, a foreign private issuer headquartered in Lausanne, Switzerland, for the month of February 2019. The filing date is February 8, 2019. The document serves primarily to incorporate by reference a press release dated February 7, 2019 (Exhibit 99.1) into the company's active registration statements (Forms F-3 and S-8).
Financial Metrics
The filing text does not provide specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed within this specific Form 6-K document.
Material Changes
The filing does not contain comparative financial data or a discussion of material changes versus prior periods. The content is limited to the procedural incorporation of a press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the body of this filing. These details are presumed to be contained within the referenced press release (Exhibit 99.1), the text of which is not included in the provided input.
Key Facts for Investor Verification
- The filing incorporates a press release dated February 7, 2019, by reference; investors must review Exhibit 99.1 for the actual news content.
- The document updates registration statements 333-224694, 333-227016, and 333-216539.
- No financial metrics or operational results are presented in this specific filing text.
- The report was signed by CEO Andrea Pfeifer and CFO Joerg Hornstein.